DC_517
CAS No. 500017-70-9
DC_517( DC-517 )
Catalog No. M14673 CAS No. 500017-70-9
DC_05 is a potent, selective, non-nucleoside DNA methyltransferase DNMT1 inhibitor with IC50 of 1.7 uM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 314 | Get Quote |
|
| 50MG | 1611 | Get Quote |
|
| 100MG | 2250 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameDC_517
-
NoteResearch use only, not for human use.
-
Brief DescriptionDC_05 is a potent, selective, non-nucleoside DNA methyltransferase DNMT1 inhibitor with IC50 of 1.7 uM.
-
DescriptionDC_05 is a potent, selective, non-nucleoside DNA methyltransferase DNMT1 inhibitor with IC50 of 1.7 uM, displays significant selectivity toward other AdoMet-dependent protein methyltransferases; significantly inhibits cancer cell proliferation in vitro.
-
In VitroDC_517 is a DNA methyltransferase 1 (DNMT1) inhibitor, with an IC50 and a Kd of 1.7 μM and 0.91 μM, respectively. DC_517 (1.25, 2.5, 5, and 10 μM) potently inhibits the proliferation of HCT116 (human colon cancer) and Capan-1 (human pancreatic adenocarcinoma cells) after treatment for 24, 48, and 72 h. DC_517 (0, 0.75, 1.5, and 3 μM) also dose-dependently induces apoptotic cell death in HCT116 cells.
-
In Vivo——
-
SynonymsDC-517
-
PathwayChromatin/Epigenetic
-
TargetDNMT
-
RecptorDNMT
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number500017-70-9
-
Formula Weight505.6499
-
Molecular FormulaC33H35N3O2
-
Purity>98% (HPLC)
-
Solubility10 mM in DMSO
-
SMILESOC(CNC(C)C)COC(CN1C2=C(C3=C1C=CC=C3)C=CC=C2)CN4C5=C(C6=C4C=CC=C6)C=CC=C5
-
Chemical Name2-Propanol, 1-[2-(9H-carbazol-9-yl)-1-(9H-carbazol-9-ylmethyl)ethoxy]-3-[(1-methylethyl)amino]-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Chen S, et al. J Med Chem. 2014 Nov 13;57(21):9028-41.
molnova catalog
related products
-
SGI-110
A novel DNA hypomethylating dinucleotide that inhibits DNA methyltransferase (DNMT).
-
Dacogen
Decitabine is indicated for treatment of patients with myelodysplastic syndrome (MDS).
-
MC3343
MC3343 (MC-3343) is a novel potent, non-nucleoside DNA methyltransferase (DNMT) inhibitor with IC50 of 5.7 and 1.7 uM for DNMT1 and DNMT3a in cell-free assays, respectively.
Cart
sales@molnova.com